PDT Partners’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$549K Sell
33,796
-58,761
-63% -$1.04M 0.03% 412
2025
Q4
$1.73M Sell
92,557
-17,152
-16% -$285K 0.11% 270
2025
Q3
$1.6M Sell
109,709
-10,618
-9% -$134K 0.1% 294
2025
Q2
$1.33M Buy
120,327
+31,750
+36% +$309K 0.08% 370
2025
Q1
$791K Buy
88,577
+50,901
+135% +$474K 0.06% 435
2024
Q4
$355K Sell
37,676
-49,501
-57% -$450K 0.03% 540
2024
Q3
$703K Buy
87,177
+20,738
+31% +$180K 0.06% 442
2024
Q2
$563K Hold
66,439
0.05% 441
2024
Q1
$596K Buy
66,439
+34,016
+105% +$315K 0.06% 421
2023
Q4
$364K Sell
32,423
-49,035
-60% -$494K 0.04% 444
2023
Q3
$703K Sell
81,458
-700
-0.9% -$6.76K 0.09% 360
2023
Q2
$850K Sell
82,158
-203
-0.2% -$2.24K 0.12% 284
2023
Q1
$894K Buy
82,361
+39
+0% +$412 0.12% 290
2022
Q4
$924K Buy
82,322
+664
+0.8% +$6.98K 0.15% 246
2022
Q3
$828K Sell
81,658
-74,473
-48% -$698K 0.13% 276
2022
Q2
$1.42M Sell
156,131
-36,570
-19% -$337K 0.12% 264
2022
Q1
$1.84M Buy
192,701
+81,322
+73% +$797K 0.16% 195
2021
Q4
$1.23M Buy
+111,379
New +$971K 0.09% 318
2021
Q1
Sell
-54,522
Closed -$969K 881
2020
Q4
$969K Sell
54,522
-11,539
-17% -$207K 0.07% 328
2020
Q3
$977K Buy
66,061
+41,447
+168% +$776K 0.06% 308
2020
Q2
$517K Buy
+24,614
New +$632K 0.04% 402
2015
Q4
Sell
-17,683
Closed -$194K 905
2015
Q3
$194K Sell
17,683
-25,244
-59% -$321K ﹤0.01% 1165
2015
Q2
$559K Buy
42,927
+26,534
+162% +$412K 0.01% 939
2015
Q1
$284K Buy
+16,393
New +$300K 0.01% 1174

Other funds holding TBPH